SCARTOZZI, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.321
AS - Asia 1.794
EU - Europa 1.399
SA - Sud America 289
Continente sconosciuto - Info sul continente non disponibili 108
AF - Africa 43
OC - Oceania 7
Totale 8.961
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.195
SG - Singapore 634
GB - Regno Unito 363
CN - Cina 301
IT - Italia 239
VN - Vietnam 232
HK - Hong Kong 220
BR - Brasile 219
FI - Finlandia 185
DE - Germania 168
BD - Bangladesh 140
SE - Svezia 139
RU - Federazione Russa 82
FR - Francia 75
TR - Turchia 67
CA - Canada 48
ID - Indonesia 39
IN - India 32
BG - Bulgaria 31
JP - Giappone 25
AR - Argentina 24
UA - Ucraina 19
IQ - Iraq 18
NL - Olanda 18
IE - Irlanda 16
VE - Venezuela 14
JO - Giordania 11
MX - Messico 11
JM - Giamaica 10
PK - Pakistan 10
ZA - Sudafrica 10
CO - Colombia 9
CW - ???statistics.table.value.countryCode.CW??? 9
EG - Egitto 9
AT - Austria 8
KR - Corea 8
TT - Trinidad e Tobago 8
BE - Belgio 7
CR - Costa Rica 7
GT - Guatemala 7
SA - Arabia Saudita 7
MY - Malesia 6
CH - Svizzera 5
CL - Cile 5
EC - Ecuador 5
HN - Honduras 5
IL - Israele 5
MA - Marocco 5
NI - Nicaragua 5
PE - Perù 5
PH - Filippine 5
PR - Porto Rico 5
RO - Romania 5
SV - El Salvador 5
UZ - Uzbekistan 5
AU - Australia 4
AZ - Azerbaigian 4
BZ - Belize 4
DK - Danimarca 4
EE - Estonia 4
LT - Lituania 4
LU - Lussemburgo 4
NO - Norvegia 4
NP - Nepal 4
OM - Oman 4
PY - Paraguay 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
CZ - Repubblica Ceca 3
GP - Guadalupe 3
KE - Kenya 3
KZ - Kazakistan 3
MQ - Martinica 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
ES - Italia 2
NZ - Nuova Zelanda 2
PL - Polonia 2
PT - Portogallo 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DM - Dominica 1
DZ - Algeria 1
GA - Gabon 1
IR - Iran 1
LV - Lettonia 1
MC - Monaco 1
Totale 8.851
Salva come PNG Salva come JPEG
Città #
Fairfield 712
Ashburn 613
Santa Clara 425
Singapore 407
Seattle 305
Woodbridge 292
Chandler 251
Houston 251
Wilmington 219
Cambridge 218
Hong Kong 216
Southend 210
San Jose 196
Helsinki 174
Council Bluffs 163
Dearborn 117
Nyköping 106
London 99
Ann Arbor 74
New York 71
Beijing 61
Izmir 58
Ho Chi Minh City 55
Hanoi 50
San Diego 47
Boardman 45
Dong Ket 44
Los Angeles 42
The Dalles 40
Lauterbourg 38
Jakarta 34
Princeton 33
Chicago 32
Milan 32
Munich 32
Phoenix 31
Sofia 31
Bremen 30
Eugene 30
Shanghai 26
Orem 25
São Paulo 24
Tokyo 22
Buffalo 20
Modena 20
Dallas 18
North Bergen 17
Redondo Beach 15
Dublin 14
Montreal 12
Atlanta 11
Jacksonville 11
Amman 10
Denver 10
Falkenstein 10
Columbus 9
Frankfurt am Main 9
Naples 9
Saint Augustine 9
Turku 9
Willemstad 9
Brooklyn 8
Cairo 8
Hefei 8
Portsmouth 8
Salt Lake City 8
Chennai 7
Da Nang 7
Haiphong 7
Kunming 7
Miano 7
Moscow 7
Norwalk 7
Rio de Janeiro 7
Seoul 7
Toronto 7
Baghdad 6
Charlotte 6
Curitiba 6
Guangzhou 6
Hanover 6
Rome 6
Salvador 6
San Francisco 6
Turin 6
Amsterdam 5
Blainville 5
Brussels 5
Clifton 5
Criciúma 5
Jieyang 5
Kingston 5
Managua 5
Mumbai 5
Vancouver 5
Baku 4
Belize City 4
Catania 4
Dhaka 4
Düsseldorf 4
Totale 6.437
Salva come PNG Salva come JPEG
Nome #
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance? 383
Multicenter prospective study of angiogenesis polymorphism validation in HCC patients treated with sorafenib. An INNOVATE study protocol 359
Treatment sequence with either irinotecan/cetuximab followed by FOLFOX-4 or the reverse strategy in metastatic colorectal cancer patients progressing after first-line FOLFIRI/bevacizumab: An Italian Group for the Study of Gastrointestinal Cancer phase III, randomised trial comparing two sequences of therapy in colorectal metastatic patients 351
Immunotherapy for colorectal cancer: where are we heading? 348
Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier) 333
Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinoma 332
Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale 327
Interplay Between SIRT-3, Metabolism and Its Tumor Suppressor Role in Hepatocellular Carcinoma 320
Effects of metformin on clinical outcome in diabetic patients with advanced HCC receiving sorafenib 315
First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: Final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial 309
The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer 306
Immunotherapeutic approaches for hepatocellular carcinoma 292
The Italian Rare Pancreatic Exocrine Cancer Initiative 291
Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New 289
eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: Final results of the ePHAS study 286
Efficacy of sorafenib in BRAF-mutated nonsmall- cell lung cancer (NSCLC) and no response in synchronous BRAF wild typehepatocellular carcinoma: A case report 279
Profile of lenvatinib in the treatment of hepatocellular carcinoma: design, development, potential place in therapy and network meta-analysis of hepatitis B and hepatitis C in all Phase III trials 274
No evidence of NRAS mutation in squamous cell anal carcinoma (SCAC) 267
Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib 265
Multimodal treatment of resectable pancreatic ductal adenocarcinoma 263
Antiangiogenic agents after first line and sorafenib plus chemoembolization: A systematic review 261
The prognostic role of hemoglobin levels in patients undergoing concurrent chemo-radiation for anal cancer 261
Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: A retrospective study 257
Multicentric prospective study of validation of angiogenesis polymorphisms in HCC patients treated with sorafenib. INNOVATE study 254
Validation of a Simple Scoring System to Predict Sorafenib Effectiveness in Patients with Hepatocellular Carcinoma 253
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy 252
Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations 249
Systemic chemotherapy for advanced rare pancreatic histotype tumors: A retrospective multicenter analysis 245
Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin 230
Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers? 201
Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus 168
The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib 141
Totale 8.961
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.146
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.146
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022467 0 0 0 0 15 45 13 49 62 76 129 78
2022/2023727 87 80 40 59 105 80 16 75 86 9 46 44
2023/2024288 9 16 10 45 65 2 33 40 3 7 8 50
2024/20251.399 39 24 5 116 286 229 141 84 190 45 75 165
2025/20262.254 125 47 97 179 366 159 310 83 227 212 246 203
2026/2027767 76 143 151 300 97 0 0 0 0 0 0 0
Totale 8.961